Market

  • NSE Code
  • BSE Code
  • ISIN
  • Industry


Company Information

Management

Mr. Lakshminarayana A

Senior Vice President

Mr. Amresh Kumar Trivedi

Deputy General Manager

Dr. M Pulla Reddy

Executive Vice President

Mr. Rajesh Chebiyam

Executive Vice President

Incorporation Year

19/09/1981

Registered Address

Registered Office : NATCO House, Road # 2, Banjara Hills,
Hyderabad, Telangana - 500034
Tel: 040-23547532
Fax: 040-23548243

Registrar Office

Venture Capital & Corporate Investments Pvt. Ltd.
"Aurum", Door No.4-50/P-II/57/4F & 5F, Plot No.57, 4th & 5th Floo
Hyderabad,500032,Telangana
Tel: 040-23818475
Fax:

Email

investors@natcopharma.co.in

Website

http://www.natcopharma.co.in

Listing

BSE, BSE, MCXSX, NSE

Corporate News

Natco Pharma - Compliances-Certificate under Reg. 74 ...

19-Apr-2025|12:26PM

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 201

Natco Pharma - Certificate under SEBI (Depositories a...

17-Apr-2025|2:08PM

Natco Pharma Limited has informed the Exchange about Certificate under SEBI

Natco Pharma has submitted to BSE the Shareholding Pa...

16-Apr-2025|1:12PM

As of March 2025, 49.56% is owned by Promoters and 50.44% by Public. Amo

Natco Pharma - Format of the Initial Disclosure to be...

09-Apr-2025|1:11PM

Format of Initial Disclosure to be made by an entity identified as a Lar

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug56.00158.78
Aarti Drug352.303,215.44
Aarti Pharma736.006,670.07
Abbott India29,720.0063,152.93
Accent Micro213.40449.06

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Tata Equity P..195.452.42
Tata Small Ca..64.450.73
Baroda BNP Pa..11.981.00
Baroda BNP Pa..8.630.70
Nippon India ..8.150.95

Board Meetings

DatePurpose
12/02/2025Quarterly Results &..
12/11/2024Quarterly Results &..
12/08/2024Quarterly Results &..
27/05/2024Audited Results
14/02/2024Quarterly Results &..